Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period.
about
Elevated platelet-derived growth factor-BB concentrations in premature neonates who develop chronic lung diseaseInterleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary DysplasiaThe Angiotensin Converting Enzyme Insertion/Deletion polymorphism is not associated with an increased risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infantsActuarial survival of a large Canadian cohort of preterm infantsUnderstanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary DysplasiaRenal follow up of premature infants with and without perinatal indomethacin exposureHeart rate characteristics and neurodevelopmental outcome in very low birth weight infants.The International Network for Evaluating Outcomes of very low birth weight, very preterm neonates (iNeo): a protocol for collaborative comparisons of international health services for quality improvement in neonatal care.Survival and major neurodevelopmental impairment in extremely low gestational age newborns born 1990-2000: a retrospective cohort study.A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe)A comparison of Wisconsin neonatal intensive care units with national data on outcomes and practices.The role of outpatient facilities in explaining variations in risk-adjusted readmission rates between hospitalsInterstitial pneumonia pattern on day 7 chest radiograph predicts bronchopulmonary dysplasia in preterm infants.Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia.Decreased free water clearance is associated with worse respiratory outcomes in premature infants.Antenatal steroid exposure and pulmonary outcomes in adolescents born with very low birth weight.Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 yearsSynchronized nasal intermittent positive-pressure ventilation and neonatal outcomesAssociation of a quality improvement program with neonatal outcomes in extremely preterm infants: a prospective cohort study.A comparison of KL-6 and Clara cell protein as markers for predicting bronchopulmonary dysplasia in preterm infantsLong term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).Persistently elevated right ventricular index of myocardial performance in preterm infants with incipient bronchopulmonary dysplasiaA longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight.Aerobic fitness and physical activity levels of children born prematurely following randomization to postnatal dexamethasone.Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung diseaseThe OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.Respiratory outcomes and atopy in school-age children who were preterm at birth, with and without bronchopulmonary dysplasia.Prediction of early outcome in resolving chronic lung disease of prematurity after discharge from hospital.Fluid restriction and prophylactic indomethacin in extremely low birth weight infants.The Evidence-based Practice for Improving Quality method has greater impact on improvement of outcomes than dissemination of practice change guidelines and quality improvement training in neonatal intensive care units.Nebulized furosemide in the treatment of bronchopulmonary dysplasia in preterm infants.Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitisNeed for supplemental oxygen at discharge in infants with bronchopulmonary dysplasia is not associated with worse neurodevelopmental outcomes at 3 years corrected age.Midtrimester preterm prelabour rupture of membranes (PPROM): expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial)Doppler assessment of pulmonary artery pressure in neonates at risk of chronic lung diseaseOpen randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants.Randomised trial of erythromycin on the development of chronic lung disease in preterm infantsPulmonary artery pressure: early predictor of chronic lung disease in preterm infants.Maternal hypertension and neurodevelopmental outcome in very preterm infantsOutcome following pulmonary haemorrhage in very low birthweight neonates treated with surfactant.
P2860
Q24795889-7CE14AC9-DC09-4660-9770-5956A1C01AB6Q24799521-7DD7D3BC-518F-472C-8BFD-425FABE7B37DQ24801612-F165EC9C-3F8A-4F99-9314-26AD6392F1D3Q24812701-9904D05D-590F-4D1B-9F07-21112EBA3112Q28087007-98257339-8272-4359-A2A9-228217CD4CAEQ28345307-2BF6432B-782E-4985-A1BF-4C7D797F8B2DQ30436651-8A7E31D8-975E-4E29-B83A-95B8DF437CC3Q30578085-045FED3D-C2EA-4DDE-91AA-82A8798FA6A7Q33283631-110786A5-941C-472A-A2DA-CDD2ACC9B85DQ33293869-95B262B7-105D-4A80-A9A2-E82E31765BDBQ33404159-EC4BBBC7-6CAE-4EC4-8DA5-1D1C4AD5FEB8Q33618718-32BAF139-617C-40D9-99C9-250F7086D21EQ33692182-8987222C-C019-469A-8C6D-24D17D12AF86Q33710305-CA41073B-D5EB-4252-A41B-8FDEB2DD854EQ33828551-BCE09E68-15F2-48F1-BABC-879AC4B6AD7AQ33829417-EE9436CE-7F2B-4760-A8A7-297CBFBE2CC1Q33962521-DF91676E-8CDB-4329-B0C8-8BDBE4108275Q34076170-BEBBDB2D-EA46-4FB9-BC84-AD6F1210DC85Q34173506-8DDBD513-C4C8-433F-AB57-0B0563CA11D7Q34177127-9B328E0B-7416-4936-A2C1-529FAC309AE5Q34187223-DC221E75-9217-435E-A049-7DF8A6C07A64Q34295848-CD13575A-E461-4F92-BCA5-C8CA16FC3706Q34336942-1CCEE81D-7989-4222-BEC0-40C80EE109D6Q34361122-3C87A4CD-1BF4-401A-8896-C120721F430DQ34503906-0155430B-DD02-4FEC-84C2-6C2E55111B63Q34538793-258068CA-93A9-4ACD-B774-AF4CBD2463EDQ34768733-45C632E4-4572-4F91-9F62-102E15A56135Q34798061-8555CDA9-140F-4F87-A0E2-F46CD7DE5261Q34985599-43180D65-2246-4FEB-B6DF-F143D8A0774DQ35099161-403ACD2D-C258-4F84-91CD-37BF0E0AC39BQ35104985-DE9175B2-6AD9-4917-B9FE-7333D00A9955Q35109111-CF047E80-C9BA-4A7B-96DC-A1880C1169CBQ35124904-61A5A7BB-DE4B-472C-9F3E-0C2F0C926303Q35141224-96F9B349-A5C8-432E-808C-1381B6BEECE7Q35285660-591B735A-65C4-4B7F-ABDC-14BF3EDB462FQ35286092-CB80EDB6-379C-42AB-865B-57FDC0DA6A21Q35286399-D7947F1E-698E-4A8B-8CB5-2FC5D6DEE529Q35286437-9003003A-3691-4041-803C-09D82508D29DQ35287344-72E23183-145D-494B-BA69-C33214CC9730Q35288392-A1320D10-AE8E-4BB3-B9A5-D79D24B6FB27
P2860
Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period.
description
1988 nî lūn-bûn
@nan
1988 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Abnormal pulmonary outcomes in ...... rement in the neonatal period.
@ast
Abnormal pulmonary outcomes in ...... rement in the neonatal period.
@en
Abnormal pulmonary outcomes in ...... rement in the neonatal period.
@nl
type
label
Abnormal pulmonary outcomes in ...... rement in the neonatal period.
@ast
Abnormal pulmonary outcomes in ...... rement in the neonatal period.
@en
Abnormal pulmonary outcomes in ...... rement in the neonatal period.
@nl
prefLabel
Abnormal pulmonary outcomes in ...... rement in the neonatal period.
@ast
Abnormal pulmonary outcomes in ...... rement in the neonatal period.
@en
Abnormal pulmonary outcomes in ...... rement in the neonatal period.
@nl
P2093
P1433
P1476
Abnormal pulmonary outcomes in ...... irement in the neonatal period
@en
P2093
P304
P407
P577
1988-10-01T00:00:00Z